F D C Ltd
NSE:FDC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cre Inc
TSE:3458
|
JP |
|
Arena Bilgisayar Sanayi ve Ticaret AS
IST:ARENA.E
|
TR |
|
Centamin PLC
LSE:CEY
|
JE |
|
Can Fin Homes Ltd
NSE:CANFINHOME
|
IN |
F D C Ltd
Total Current Assets
F D C Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F D C Ltd
NSE:FDC
|
Total Current Assets
₹11.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Current Assets
₹279.6B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Current Assets
₹249.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Current Assets
₹601.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
7%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Total Current Assets
₹202.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Current Assets
₹61.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
F D C Ltd
Glance View
FDC Ltd. engages in the business of pharmaceutical. The company is headquartered in Mumbai, Maharashtra. The firm manufactures and distributes its range of generics, formulations and active pharmaceuticals at its manufacturing plants. The company also manufactures oral rehydration salts (ORS) and specialized formulations. The company has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. The company has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
See Also
What is F D C Ltd's Total Current Assets?
Total Current Assets
11.3B
INR
Based on the financial report for Dec 31, 2025, F D C Ltd's Total Current Assets amounts to 11.3B INR.
What is F D C Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
2%
Over the last year, the Total Current Assets growth was -1%. The average annual Total Current Assets growth rates for F D C Ltd have been 4% over the past three years , 2% over the past five years .